Business Description
Genocea Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US3724271040
Description
Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by next-generation sequencing of that patient's tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, or Inhibigens , that drive pro-tumor immune responses.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -90 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -2685.82 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-EBIT | -0.94 | |||||
| EV-to-Forward-EBITDA | -0.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GNCAQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genocea Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.911 | ||
| EPS (TTM) ($) | -0.66 | ||
| Beta | 54.06 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 1.62 | ||
| Volatility % | 90 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000006 | ||
| 20-Day SMA ($) | 0.00001 | ||
| 12-1 Month Momentum % | -90 | ||
| 52-Week Range ($) | 0.00001 - 0.0001 | ||
| Shares Outstanding (Mil) | 58.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genocea Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genocea Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genocea Biosciences Inc Frequently Asked Questions
What is Genocea Biosciences Inc(GNCAQ)'s stock price today?
The current price of GNCAQ is $0.00. The 52 week high of GNCAQ is $0.00 and 52 week low is $0.00.
When is next earnings date of Genocea Biosciences Inc(GNCAQ)?
The next earnings date of Genocea Biosciences Inc(GNCAQ) is 2025-07-18 Est..
Does Genocea Biosciences Inc(GNCAQ) pay dividends? If so, how much?
Genocea Biosciences Inc(GNCAQ) does not pay dividend.
Guru Commentaries on OTCPK:GNCAQ
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers